Filing Details

Accession Number:
0001477449-24-000191
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-04 16:12:35
Reporting Period:
2024-08-30
Accepted Time:
2024-09-04 16:12:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1375088 C Adam Vandervoort C/O Teladoc Health, Inc.,
2 Manhattanville Road, Suite 203
Purchase NY 10577
Chief Legal Officer, Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-30 1,505 $0.00 42,769 No 4 M Direct
Common Stock Acquisiton 2024-08-30 1,881 $0.00 44,650 No 4 M Direct
Common Stock Acquisiton 2024-08-30 4,417 $0.00 49,067 No 4 M Direct
Common Stock Disposition 2024-09-03 2,817 $7.16 46,250 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Units Disposition 2024-08-30 1,505 $0.00 1,505 $0.00
Common Stock Restricted Stock Units Disposition 2024-08-30 1,881 $0.00 1,881 $0.00
Common Stock Restricted Stock Units Disposition 2024-08-30 4,417 $0.00 4,417 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,035 No 4 M Direct
3,762 No 4 M Direct
26,508 No 4 M Direct
Footnotes
  1. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  4. The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  5. On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  6. On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.